EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 3.0

Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG)

Elżbieta Iskierka-Jażdżewska, Klaudia Zielonka, Bartosz Puła, Agnieszka Chudy, Monika Kustra, Beata Brodacka, Edyta Subocz, Alina Urbanowicz, Dominika Wiśniewska-Organek, Anna Dąbrowska-Iwanicka, Aneta Kozak-Białek, Natalia Leończuk und 10 weitere

Advances in Clinical and Experimental Medicine · 15.10.2026 · 35 (10) · 1725-1734

DOI: 10.17219/acem/215822 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Advances in Clinical and Experimental Medicine, online erschienen am 15.10.2026. Verfasst von Elżbieta Iskierka-Jażdżewska und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital, Łódź, Poland. Hauptthemen laut MEDLINE: Adenine, Piperidines, Leukemia, Lymphocytic, Chronic, B-Cell, Mutation. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdeninePiperidinesLeukemia, Lymphocytic, Chronic, B-CellMutationTumor Suppressor Protein p53PyrazolesPyrimidinesProtein Kinase InhibitorsAntineoplastic AgentsHumansRetrospective StudiesFemaleAgedPolandMaleMiddle AgedAged, 80 and overTreatment OutcomeRecurrence

Stichwörter der Autor:innen

TP53 mutationschronic lymphocytic leukemiaibrutinibnext-generation sequencing

Substanzen

ibrutinibAdeninePiperidinesTumor Suppressor Protein p53TP53 protein, humanPyrazolesPyrimidinesProtein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital, Łódź, Poland.
  • Department of Hematology, Medical University of Lodz, Poland.
  • Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Poland.
  • Department of Tumor Biology and Genetics, Medical University of Warsaw, Poland.
  • Department of Hematology, University Hospital in Rzeszów, Poland.
  • Department of Hematology, Internal Medicine and Bone Marrow Transplantation, Clinical Hospital of the Ministry of Internal Affairs and Administration with the Warmia-Mazury Oncology Centre in Olsztyn, Poland.

Zitieren

APA

Iskierka-Jażdżewska, E., Zielonka, K., Puła, B., Chudy, A., Kustra, M., Brodacka, B., Subocz, E., Urbanowicz, A., Wiśniewska-Organek, D., Dąbrowska-Iwanicka, A., Kozak-Białek, A., Leończuk, N., Łuksza, E., Markiewicz, M., Morawska, M., Oller, M., Radwański, S., Szeremet, A., Tomczak, W., …, & Jamroziak, K. (2026). Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG). Advances in Clinical and Experimental Medicine, 35(10), 1725-1734. https://doi.org/10.17219/acem/215822

Vancouver

Iskierka-Jażdżewska E, Zielonka K, Puła B, Chudy A, Kustra M, Brodacka B, et al. Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG). Advances in Clinical and Experimental Medicine. 2026;35(10):1725-1734. doi:10.17219/acem/215822

BibTeX
@article{IskierkaJadewska2026,
  author = {Iskierka-Jażdżewska, Elżbieta and Zielonka, Klaudia and Puła, Bartosz and Chudy, Agnieszka and Kustra, Monika and Brodacka, Beata and Subocz, Edyta and Urbanowicz, Alina and Wiśniewska-Organek, Dominika and Dąbrowska-Iwanicka, Anna and Kozak-Białek, Aneta and Leończuk, Natalia and Łuksza, Ewa and Markiewicz, Mirosław and Morawska, Marta and Oller, Marta and Radwański, Sławomir and Szeremet, Agnieszka and Tomczak, Waldemar and Górecki, Tomasz and Stokłosa, Tomasz and Jamroziak, Krzysztof},
  title = {Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG)},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2026},
  volume = {35},
  number = {10},
  pages = {1725--1734},
  doi = {10.17219/acem/215822}
}
Kostenlos starten →